Hims vs Sprout Health: Which GLP-1 Provider Is Better?
Short answer: Hims scores higher on our rubric, 7.9/10 against 5.8/10. Full reasoning, pricing and the cases where the other one wins are below.
Hims beats Sprout Health overall, scoring 7.9/10 vs 5.8/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; Sprout Health is $199 first month, then $249/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Sprout Health for users who want a dedicated care coordinator and locked titration pricing, and will judge service quality in month one.
A side-by-side look at Hims and Sprout Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hims
#7 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit HimsSprout Health
#45 of 54Well-established telehealth provider offering both compounded and brand-name GLP-1 medications with solid clinical support.
Visit Sprout Health| Feature | Hims | Sprout Health |
|---|---|---|
| Why each one | The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers. | The most consistent telehealth GLP-1 provider since 2022, no pricing changes, no service disruptions, and published outcome data that backs up their claims. |
| Our Score | 7.9/10 | 5.8/10 |
| Headline Price | $188 first month, then $298/mo | $199 first month, then $249/mo |
| Medication Type | Brand | Both |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | Users who want a dedicated care coordinator and locked titration pricing, and will judge service quality in month one |
| Watch out for | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. | $250/mo all-in sits in the upper-mid range, $90 more than Willow for a similar model; the premium pays for the dedicated coordinator and published outcomes |
| Ranking | #7 | #45 |
| Get started | Visit Hims | Visit Sprout Health |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Sprout Health
Pros
- +Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
- +Dedicated care coordinator assigned to each patient, not a rotating pool of providers
- +Transparent pricing: $250/mo covers medication, shipping, and all consultations
- +Operating since 2022 with a consistent track record, no sudden pricing changes or service disruptions
Cons
- −$250/mo all-in sits in the upper-mid range, $90 more than Willow for a similar model; the premium pays for the dedicated coordinator and published outcomes
- −No insurance accepted, and no superbill provided for FSA/HSA reimbursement
Our Verdict
Hims edges out Sprout Health with a score of 7.9/10 vs 5.8/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; Sprout Health is $199 first month, then $249/mo. Sprout Health offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hims and Sprout Health.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Hims vs Henry Medsfrom $199/mo
- Hims vs Ivim Healthfrom $150/mo
- Hims vs Mochi Healthfrom $178/mo
- Sprout Health vs Breeze Medsfrom $199/mo
- Sprout Health vs SkinnyRxfrom $199/mo
- Sprout Health vs Bodybuilding Health+from $179/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Hims · 7.9/10